AdvaMed Praises Introduction of Bipartisan Cures 2.0 Bill
WASHINGTON, D.C. – Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker on the introduction by U.S. Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) of their bipartisan “Cures 2.0” legislation:
“This bipartisan legislation builds on the 2015 Cures law, which was truly transformational for patients and medical innovation. We thank Reps. DeGette and Upton for their continued leadership with the introduction of Cures 2.0. We are especially pleased that this legislation includes Reps. DelBene and Walorski’s proposal to ensure Medicare patients are given immediate access to lifesaving ‘breakthrough’ medical technologies. This is a proven and powerful way to spur greater medical innovation and help our Medicare patients live longer, healthier, and happier lives. We urge Congress to pass this important bipartisan legislation to support American medical innovation and the patients we serve.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.